Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

被引：35
|
作者：
Su, Qiang [1 ]
Li, Qinghua [1 ]
机构：
[1] Guilin Med Univ, Affiliated Hosp, Guilin, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 10期
关键词：
SYSTEMIC EMBOLISM; WARFARIN;
D O I：
10.1056/NEJMc1809065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：986 / 986
页数：1
相关论文
共 50 条
  • [41] XANTUS, a prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
    Postula, Marek
    Kosior, Dariusz
    KARDIOLOGIA POLSKA, 2015, 73 : 71 - 75
  • [42] Stroke prevention
    Lains, J.
    Campos, I.
    Morais, F.
    Casalta, P.
    6TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF PHYSICAL AND REHABILITATION MEDICINE, 2011, : 185 - +
  • [43] Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke
    Ritzenthaler, T.
    Derex, L.
    Davenas, C.
    Bnouhanna, W.
    Farghali, A.
    Mechtouff, L.
    Cho, T. -H.
    Nighoghossian, N.
    REVUE NEUROLOGIQUE, 2015, 171 (8-9) : 613 - 615
  • [44] Recurrent embolic strokes of Undetermined source in a patient with extreme Lipoprotein(a) Levels
    Bulwa, Zachary
    Kim, Audrey
    Singh, Karandeep
    Kantorovich, Alexander
    Suhail, Faten
    FRONTIERS IN NEUROLOGY, 2016, 7
  • [45] A critical assessment of the current pharmacotherapy for the treatment of embolic strokes of undetermined source
    Lattanzi, Simona
    Acampa, Maurizio
    Norata, Davide
    Broggi, Serena
    Caso, Valeria
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (08) : 905 - 915
  • [46] Prevention of heart embolic complications in atrial fibrillation: Possibilities of using rivaroxaban
    Yavelov, I. S.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (12) : 119 - 126
  • [47] Stroke prevention after stroke in patients with atrial fibrillation: A case-based review
    Kovacs Tibor
    ORVOSI HETILAP, 2014, 155 (42) : 1655 - 1660
  • [48] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
    Wang, Ye
    Xie, Feng
    Kong, Ming Chai
    Lee, Lai Heng
    Ng, Heng Joo
    Ko, Yu
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (06) : 575 - 585
  • [49] Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
    Camm, A. John
    Coleman, Craig I.
    Larsen, Torben Bjerregaard
    Nielsen, Peter Bronnum
    Tamayo, Sally
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 : S45 - S60
  • [50] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
    Ye Wang
    Feng Xie
    Ming Chai Kong
    Lai Heng Lee
    Heng Joo Ng
    Yu Ko
    Cardiovascular Drugs and Therapy, 2014, 28 : 575 - 585
12345